Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 621

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 621
---
b), (c) and (d) for such violations, conflicts, breaches, defaults, terminations, accelerations or Liens
that would not have a Purchaser Material Adverse Effect.

4.4 Requisite Governmental Approvals. No
Consent of any Governmental Authority is required on the part of Purchaser or any of its Affiliates in connection with the (a) execution and delivery of this Agreement by Purchaser; (b) performance by Purchaser of its covenants and
obligations pursuant to this Agreement; or (c) consummation of the Stock Purchase, except (i) such filings with Governmental Authorities to satisfy the applicable Laws of states in which the Company is qualified to do business;
(ii) such filings and approvals as may be required by any federal or state securities Laws, including compliance with any applicable requirements of the Exchange Act; (iii) compliance with any applicable requirements of the HSR Act and any
applicable Regulatory Laws; and (iv) such other Consents the failure of which to obtain would not have a Purchaser Material Adverse Effect.

4.5 Legal Proceedings; Orders.

(a) No Legal Proceedings. There are no Legal Proceedings pending or, to the Knowledge of Purchaser, threatened against Purchaser that
would have a Purchaser Material Adverse Effect.

(b) No Orders. Purchaser is not subject to any order of any kind or nature that
would have a Purchaser Material Adverse Effect.

4.6 Ownership of Seller Capital Stock. None of
Purchaser or any of its Affiliates, nor to the Knowledge of Purchaser, any of its respective directors or officers is or has been an “interested stockholder” (as defined in Section 203 of the DGCL) of Seller during the three
(3) years prior to the date of this Agreement.

4.7 Brokers. There is no financial advisor,
investment banker, broker, finder, agent or other Person that has been retained by or is authorized to act on behalf of Purchaser or any of its Affiliates who is entitled to any financial advisor, investment banking, brokerage, finder’s or
other similar fee or commission in connection with the Stock Purchase for which Seller or any of its Subsidiaries would be liable.

A-49

4.8 No Purchaser Vote or Approval Required. No vote or
consent of the holders of any capital stock of, or other equity or voting interest in, Purchaser is necessary to approve